Cara Therapeutics (CARA)
NASDAQ:CARA

Cara Therapeutics Similar Stocks

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cara Therapeutics
$465.17M
-4.86
-35.03%
4Buy
0Hold
0Sell
Strong Buy
$26.00
premium
premium
Assertio Therapeutics
$143.12M
49.22
+108.61%
1Buy
0Hold
0Sell
Moderate Buy
$6.00
premium
premium
Collegium Pharmaceutical
$531.68M
18.10
-36.17%
6Buy
0Hold
0Sell
Strong Buy
$33.60
premium
premium
Acelrx
$37.51M
-0.87
-79.84%
0Buy
1Hold
0Sell
Hold
premium
premium
Pacira Pharmaceuticals
$2.89B
75.79
-4.35%
6Buy
2Hold
0Sell
Strong Buy
$82.63
premium
premium
KemPharm
$171.43M
-1.67
-50.40%
1Buy
0Hold
0Sell
Moderate Buy
$11.00
premium
premium

Performance Comparison

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis